Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 14 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 11382899

    Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

    The Board of Regents of the University of Texas System · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted
  2. US 11376324

    Sting activating nanovaccine for immunotherapy

    The Board of Regents of the University of Texas System · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted
  3. US 11377491

    Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer

    The Board of Regents of the University of Texas System · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted
  4. US 11370757

    Photocleavable nitroindoline-based crosslinkers

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  5. US 11369716

    Reparative cell isolation and delivery

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  6. US 11370786

    GLS1 inhibitors for treating disease

    The Board of Regents of the University of Texas System · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  7. US 11365183

    Eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  8. US 11365413

    Inhibition of poly(A) binding protein and the treatment of pain

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  9. US 11365189

    Heterocyclic inhibitors of tyrosine kinase

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  10. US 11365250

    Compositions and methods for cancer therapy

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  11. US 11364197

    Compositions and methods of making brittle-matrix particles through blister pack freezing

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  12. US 11358991

    Heme sequesting peptides and uses therefor

    The Board of Regents of the University of Texas System · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  13. US 11344578

    Immune cells expressing engineered antigen receptors

    The Board of Regents of the University of Texas System · Granted May 31, 2022 · Expires May 26, 2042

    granted
  14. US 11345659

    Pipecolic esters for inhibition of the proteasome

    The Board of Regents of the University of Texas System · Granted May 31, 2022 · Expires May 26, 2042

    granted
  15. US 11344577

    Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

    The Board of Regents of the University of Texas System · Granted May 31, 2022 · Expires May 26, 2042

    granted
  16. US 11331333

    Treatment of aberrant fibroblast proliferation

    The Board of Regents of the University of Texas System · Granted May 17, 2022 · Expires May 12, 2042

    granted
  17. US 11332483

    Naphthoquinone containing gold carbene complexes and methods of uses thereof

    The Board of Regents of the University of Texas System · Granted May 17, 2022 · Expires May 12, 2042

    granted
  18. US 11325898

    Small molecule inducers of autophagy

    The Board of Regents of the University of Texas System · Granted May 10, 2022 · Expires May 5, 2042

    granted
  19. US 11318186

    Use of FGF21 in methods of increasing exocrine pancreatic secretion

    The Board of Regents of the University of Texas System · Granted May 3, 2022 · Expires Apr 28, 2042

    granted
  20. US 11313868

    Methods of detecting anti-folic acid antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted
  21. US 11304916

    Methods and compositions for the treatment of Shiga Toxicosis

    The Board of Regents of the University of Texas System · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  22. US 11304911

    Compositions and methods for organ specific delivery of nucleic acids

    The Board of Regents of the University of Texas System · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  23. US 11299512

    Cyclic di-nucleotide compounds and methods of use

    The Board of Regents of the University of Texas System · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted
  24. US 11293024

    Antisense antibacterial compounds and methods

    The Board of Regents of the University of Texas System · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted